Autoantibody level modification in adult patients with idiopathic thrombocytopenic purpura following intravenous immunoglobulin treatment

scientific article

Autoantibody level modification in adult patients with idiopathic thrombocytopenic purpura following intravenous immunoglobulin treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000069447
P698PubMed publication ID11061589

P50authorYehuda ShoenfeldQ1515807
Yair LevyQ73255332
Yaniv ShererQ73298682
P2093author name stringAhmed A
Peter JB
Shen GQ
Fabbrizzi F
Terryberry J
P433issue5-6
P921main subjectthrombocytopeniaQ585285
autoimmune thrombocytopenic purpuraQ638729
autoantibodyQ785022
P304page(s)207-214
P577publication date1998-01-01
P1433published inNatural ImmunityQ27709928
P1476titleAutoantibody level modification in adult patients with idiopathic thrombocytopenic purpura following intravenous immunoglobulin treatment
P478volume16

Reverse relations

cites work (P2860)
Q33394149Current treatment options for primary immune thrombocytopenia
Q36359673Facing the enigma of immunomodulatory effects of intravenous immunoglobulin
Q35194511IVIG in autoimmunity and cancer--efficacy versus safety
Q37773248Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science
Q39248920Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions
Q38039852Platelets in inflammation and immune modulations: functions beyond hemostasis
Q80953233[Immunomodulatory effects of intravenous immunoglobulins]

Search more.